J
JUBLPHARMA
₹1,126.70
+3.40 (0.30%)

Jubilant Pharmova Ltd. (JUBLPHARMA) live share price today at NSE / BSE

Overview
Charts
Results
News & Events

Expert Verdict for Jubilant Pharmova Ltd. (JUBLPHARMA) Share

View details
Today`s low
0.00
Today`s high
0.00
Today`s return
Jubilant Pharmova Ltd. (JUBLPHARMA) Share Price Today
Performance Of Jubilant Pharmova Ltd. (JUBLPHARMA) Share Today
Opening Price:1,128.10
Previous closing Price:1,123.30
Volume of Jubilant Pharmova Ltd. (JUBLPHARMA) share:4,11,715
Value of Share:1,126.70
Fundamental of Jubilant Pharmova Ltd. (JUBLPHARMA) Share Price
Market Capitalisation:17,945 Cr.
P/E Ratio:21.38
P/B Ratio:2.87
Sector P/E:43.31
EPS (TTM):52.70
Dividend Yield:0.44
14D - RSI:60.76
50 DMA:1,006.18
200 DMA:1,042.67

Note: The above data is mentioned as per the Jubilant Pharmova Ltd. (JUBLPHARMA) share price today.

Jubilant Pharmova Ltd. (JUBLPHARMA) Share Price Today At NSE

    • Live Jubilant Pharmova Ltd. (JUBLPHARMA) Share Price NSE India: ₹1,126.70
    • Previous Closing Price: ₹1,123.30
    • Open Price: ₹1,128.10
    • High: ₹1,148.00
    • Low: ₹1,116.90

Jubilant Pharmova Ltd. (JUBLPHARMA) Share Price Today At BSE

  • Live Jubilant Pharmova Ltd. (JUBLPHARMA) Share Price BSE India: ₹1,124.40
  • Previous Closing Price: ₹1,122.95
  • Open Price: ₹1,113.05
  • High: ₹1,147.70
  • Low: ₹1,113.05

Historical Price Of Jubilant Pharmova Ltd. (JUBLPHARMA) Share

The table below shows the variations in Jubilant Pharmova Ltd. (JUBLPHARMA) share price from January 2018 to June 2025.

Month & YearPrice (INR)Open Price (INR)High Price (INR)Low Price (INR)Volume (Cr.)Change %
January 2018913.35787.40974.00752.302,57,22,79916
February 2018877.50919.901,039.00845.003,34,04,701-4.61
March 2018839.45881.95884.25780.001,43,36,358-4.82
April 2018879.60845.75890.00736.0595,47,2114
May 2018789.20879.80886.45771.001,14,47,570-10.3
June 2018699.15790.00801.70685.6582,80,362-11.5
July 2018738.90705.35819.70691.5064,95,7684.76
August 2018722.20742.60789.60706.9571,95,357-2.75
September 2018732.70727.90868.80686.0588,58,8090.66
October 2018663.55735.50735.50586.3567,53,791-9.78
November 2018774.80664.40780.00663.1050,68,24716.62
December 2018710.60780.00846.35695.1066,41,876-8.9
January 2019703.45715.40769.80697.0548,76,220-1.67
February 2019783.50705.10797.00705.0063,58,26011.12
March 2019664.80787.90898.85648.152,41,55,000-15.62
April 2019660.85670.95726.90645.2072,44,645-1.51
May 2019495.25660.05663.35490.5079,29,841-24.97
June 2019512.10495.00524.35450.3078,16,2923.45
July 2019439.35515.30525.80425.001,20,10,291-14.74
August 2019439.20440.00459.00391.0556,47,124-0.18
September 2019505.15437.00572.40425.701,19,34,56615.59
October 2019552.35508.30583.80467.0063,75,5948.67
November 2019510.20560.00564.70488.0039,08,534-8.89
December 2019537.00515.60559.80496.0038,05,1474.15
January 2020582.55537.00639.95520.0083,05,6648.48
February 2020506.30572.00588.00488.5536,02,574-11.49
March 2020249.20515.00523.80234.3562,68,958-51.61
April 2020400.25262.00443.00251.7567,04,74552.77
May 2020442.15391.90496.00363.0064,43,67312.82
June 2020655.45464.25695.90464.251,89,80,51241.18
July 2020795.00660.00814.50653.001,36,09,64720.45
August 2020783.25796.00909.00762.001,63,71,451-1.6
September 2020730.95784.00840.00686.001,44,11,852-6.77
October 2020728.45737.00784.40682.5554,43,248-1.16
November 2020723.00728.80746.95679.0049,43,813-0.8
December 2020844.90729.00897.90712.751,29,63,17815.9
January 2021891.40848.001,010.00838.851,18,50,0435.12
February 2021769.60882.001,046.95638.3041,94,099-12.74
March 2021681.10777.70806.70634.1033,62,736-12.42
April 2021798.50701.00834.00681.8088,95,92013.91
May 2021873.55798.50925.00783.0572,27,3729.4
June 2021732.25878.80880.00711.0070,56,532-16.68
July 2021686.60732.25767.00659.0599,71,679-6.23
August 2021663.30695.00695.00585.0563,55,715-4.56
September 2021623.65669.25677.85596.0547,54,280-6.81
October 2021596.20620.00655.50585.0543,62,828-3.84
November 2021583.85610.00626.00580.3018,91,578-4.29
December 2021586.60590.00614.35557.0020,78,813-0.58
January 2022519.15593.45594.90516.0519,27,266-12.52
February 2022397.05520.10537.40391.5541,89,133-23.66
March 2022388.15397.05462.00385.1557,66,300-2.24
April 2022471.65392.00495.95390.3036,97,34620.32
May 2022384.25471.65476.50378.0519,65,338-18.53
June 2022343.70397.00405.00318.8015,30,936-13.43
July 2022361.40348.80380.00281.8018,65,8853.61
August 2022350.55363.00387.00335.0035,86,069-3.43
September 2022335.95349.40360.00305.0569,70,804-3.85
October 2022367.05335.95391.95318.4545,65,7009.26
November 2022391.55368.90404.70364.3040,77,6196.14
December 2022374.75391.55423.90362.6067,82,500-4.29
January 2023352.00379.20379.20331.0515,85,133-7.17
February 2023305.95353.90367.60304.0018,13,265-13.55
March 2023278.85304.25325.00268.9079,39,776-8.35
April 2023311.75279.90318.75279.6015,78,11211.38
May 2023330.10310.05367.70305.0062,50,5196.47
June 2023398.55331.40418.90329.6546,68,17520.26
July 2023377.35399.85410.65363.6037,10,846-5.63
November 2023429.45376.50443.90370.4577,40,50414.06
December 2023545.45431.55550.80428.751,36,58,22526.39
January 2024571.45572.00598.20532.151,18,21,302-0.1
February 2024568.20574.00627.45546.151,26,55,813-1.01
March 2024569.90569.00612.00538.0553,48,0650.16
April 2024674.20572.90724.40566.601,37,88,74717.68
May 2024688.05677.60741.00660.0074,10,3611.54
June 2024739.75696.00775.00617.0555,05,4176.29
July 2024773.25733.00800.00701.8080,58,2095.49
August 2024919.50781.00950.50778.602,15,87,37617.73
September 20241,150.80924.301,247.15904.052,66,48,46824.51
October 20241,211.751,145.701,232.001,033.1557,25,3235.77
November 20241,234.251,235.001,309.901,085.8052,66,242-0.06
December 20241,105.201,225.001,265.001,050.0044,03,411-9.78
January 2025973.951,105.201,130.000.0052,69,150-11.88
February 2025902.70982.151,074.35878.0576,19,151-8.09
March 2025895.90904.95940.00845.8040,99,107-1
April 2025897.95885.00995.00802.0076,34,8951.46
May 20251,173.80897.901,175.00840.001,06,31,08930.73
June 20251,126.701,173.801,192.701,060.001,00,98,393-4.01

Shareholding Pattern of Jubilant Pharmova Ltd. (JUBLPHARMA) Shares In Stock Market

The below depicted shareholding pattern is as per the Jubilant Pharmova Ltd. (JUBLPHARMA) Industries Ltd. Share Price Market of March 2025.

Promoters50.68%
Foreign Institutions17.23%
Retail and Others27.07%
Other Domestic Institutions1.36%
Mutual Funds3.66%
Jubilant Pharmova Ltd. (JUBLPHARMA) Share Background
Face Value1.00
ISININE700A01033
Market Lot1.00
InstrumentEQUITY
Should you invest in Jubilant Pharmova Ltd. (JUBLPHARMA) Industries Limited?
  • Every milestone results from a lot of hard work, effort, and making the correct decisions, but patience is essential.
  • Patience is the key to success in the share market, which is also important in attaining benefits on Jubilant Pharmova Ltd. (JUBLPHARMA) share price.
  • In terms of investment, the investor’s patience pays off with a high return, which is why long-term investors are the most successful.
  • Jubilant Pharmova Ltd. (JUBLPHARMA) Industries has produced a great return to the last year and is reaching new milestones daily; it has become the first Indian firm to attain a market capitalisation of 17,945 Cr.
  • Jublpharma FAQs

    Is Jubilant Pharmova Ltd. a good stock to invest in?

    arrow

    Our expert verdict states that Jubilant Pharmova Ltd. is in Buy zone for Short term and is in Hold zone for Long term.

    Should I buy Jubilant Pharmova Ltd. share now?

    arrow

    As per our verdict, Jubilant Pharmova Ltd. is in the Buy zone for Short term.

    Should I buy Jubilant Pharmova Ltd. shares for the long term?

    arrow

    As per our verdict, Jubilant Pharmova Ltd. is in Hold zone for Long term.

    What is Jubilant Pharmova Ltd. share price today?

    arrow

    The Jubilant Pharmova Ltd. share price today is 1126.7.

    How to buy Jubilant Pharmova Ltd. share?

    arrow

    You can buy Jubilant Pharmova Ltd. shares on any demat broker by completing your KYC. Before buying any stock, check BUY/SELL/HOLD insights on the Univest App.

    What is the share price of Jubilant Pharmova Ltd.?

    arrow

    The share price of Jubilant Pharmova Ltd. is 1126.7, please note that the price may vary on a real-time basis.

    What is the PE and PB ratio of Jubilant Pharmova Ltd.?

    arrow

    PE ratio of Jubilant Pharmova Ltd. is 21.38 and PB ratio of Jubilant Pharmova Ltd. is 2.87.

    How’s PE of Jubilant Pharmova Ltd. compared to its sector?

    arrow

    PE ratio of Jubilant Pharmova Ltd. is 21.38 whereas the sector PE ratio is 43.31.

    What is the market cap of Jubilant Pharmova Ltd.?

    arrow

    Jubilant Pharmova Ltd.’s market cap is 17944.6.

    What are today’s High and Low prices of Jubilant Pharmova Ltd. ?

    arrow

    Today’s High of Jubilant Pharmova Ltd. is 1148.
    Today’s Low of Jubilant Pharmova Ltd. is 1116.9.

    icon

    100% Safe & Secure Platform.

    Univest encrypts all data and transactions to ensure a completely secure experience for our members.

    Copyright

    2025 Univest. All rights reserved. | Designed with ❤️ in India
    About Univest
    About: Univest is a cutting-edge stock market platform designed to help traders and investors maximize their returns with expert-driven advisory services and seamless trading execution. Whether you're a seasoned trader or just starting, Univest simplifies your investment journey with actionable trade recommendations, AI-powered portfolio insights, and a fully integrated brokerage experience. With Univest, you gain access to proven stock market advisory, offering expert trade ideas for stocks, futures, options, and commodities. Our one-click trade execution feature eliminates slippage, ensuring instant execution through our advisory-first brokerage. Smart portfolio management allows you to identify underperforming stocks, optimize your investments, and receive real-time alerts. Additionally, Univest provides seamless investment opportunities beyond stocks, including mutual funds, bonds, fixed deposits, and insurance (coming soon). Join over 40 lakh active investors who trust Univest to make informed and profitable trading decisions. Start investing smarter today! 🚀  
    Attention Investors : To ensure a smooth trading experience and prevent unauthorized transactions, investors must update their mobile number and email ID with their stockbroker or depository participant. As per regulatory requirements, investors are required to pay a stipulated amount as an upfront margin for trading in the Cash/FO segment. We encourage all investors to regularly check their securities in the Consolidated Account Statement (CAS) issued by depository to verify their holdings.Always verify alerts and transaction details received directly from the exchange or NSDL before proceeding with any trades. Please do not make payments through unverified email links, WhatsApp, or SMS. Always trade through a registered stockbroker and verify all details before making financial decisions.
     
    Disclaimer: Investments in the securities market are subject to market risks. Please read all related documents carefully before investing. Brokerage will not exceed the SEBI prescribed limit. For more disclaimer /disclosure, visit https://univest.in/stock-broker or Univest App.We collect and use your contact information for legitimate business purposes, including providing updates on our products and services. We do not sell or rent your contact information to third parties. By submitting your details, you authorize us to contact you via Call/SMS, even if you are registered under DND. This authorization remains valid for 12 months.For grievances, please contact us at hello@unibrokers.in .
     
    Univest Stock Broking Disclosures
    Univest Stock Broking Private Limited - SEBI Reg. No. INZ000317437 (Stock Broker), NSE TM Code: 90392, BSE TM Code: 6866, MCX TM Code: 57290 and ICCL- Self Clearing Member Code: 6866, SEBI Reg. No. IN-DP-779-2024 (Participant), NSDL DP ID: IN304748.
     Risk Disclosures on Derivatives
    1. 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
    2. On an average, loss makers registered net trading loss close to ₹ 50,000
    3. Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
    4. Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
    Attention Investors: As per NSE circular dated July 6, 2022: https://nsearchives.nseindia.com/content/circulars/INSP52900.pdf, BSE circular dated July 6, 2022: https://www.bseindia.com/markets/MarketInfo/DispNewNoticesCirculars.aspx?page=20220706-55, MCX circular dated July 11, 2022: https://www.mcxindia.com/docs/default-source/circulars/english/2022/july/circular-418-2022.pdf?sfvrsn=9401991_0, investors are cautioned to abstain them from dealing in any schemes of unauthorised collective investments/portfolio management, indicative/ guaranteed/fixed returns / payments etc. 
    Investors are further cautioned to avoid practices like:
    a. Sharing 
    i) trading credentials – login id and passwords including OTPs.
    ii) trading strategies,
    iii) position details.
    b. Trading in leveraged products /derivatives like Options without proper understanding, which could lead to losses.
    c. Writing/ selling options or trading in option strategies based on tips, without basic knowledge and understanding of the product and its risks.
    d. Dealing in unsolicited tips through platforms like Whatsapp, Telegram, Instagram, YouTube, Facebook, SMS, calls, etc.
    e. Trading / Trading in “Options” based on recommendations from unauthorised / unregistered investment advisors and influencers.
     Kindly read the Advisory Guidelines For Investors as prescribed by the Exchange with reference to their circular dated 27th August, 2021 regarding investor awareness and safeguarding client’s assets: https://nsearchives.nseindia.com/content/circulars/INSP49434.pdf
    Kindly, read the advisory as prescribed by the Exchange with reference to their circular: NSE/ISC/51035 dated January 14, 2022 regarding Updation of mandatory KYC fields by March 31, 2022: https://www.nseindia.com/resources/exchange-communication-circulars# 
    Attention Investors: Prevent unauthorised transactions in your Demat account by updating your mobile number with your depository participant. Receive alerts on your registered mobile number for debit and other important transactions in your Demat account directly from NSDL on the same day. Prevent unauthorised transactions in your Trading account by updating your mobile numbers/email addresses with your stock brokers. Receive information on your transactions directly from the Exchange on your mobile/email at the end of the day. Issued in the interest of investors. KYC is a one-time exercise while dealing in securities markets - once KYC is done through a SEBI-registered intermediary (Broker, DP), you need not undergo the same process again when you approach another intermediary. As a business, we don’t give stock tips and have not authorised anyone to trade on behalf of others. If you find anyone claiming to be part of Univest Stock Broking Private Limited and offering such services, please send us an email at hello@unibrokers.in
    No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor’s account.
    Update your email ID and mobile number with your stockbroker/depository participant and receive an OTP directly from the depository on your registered email ID and/or mobile number. Check your securities/mutual funds/bonds in the Consolidated Account Statement (CAS) issued by NSDL every month.
    Attention Investors: SEBI has established an Online Dispute Resolution Portal (ODR Portal) for resolving disputes in the Indian Securities Market. This circular streamlines the existing dispute resolution mechanism, offering online conciliation and arbitration, benefiting investors and listed companies https://www.sebi.gov.in/legal/circulars/jul-2023/online-resolution-of-disputes-in-the- indian-securities-market_74794.html. ODR portal for Investors - https://smartodr.in/login.
    Procedure to file a complaint on SEBI SCORES: Register on SCORES portal. Mandatory details for filing complaints on SCORES: Name, PAN, Address, Mobile Number, E-mail ID. Benefits: Effective Communication, Speedy redressal of the grievances.
    arrow down